IBDEI0WK ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16079,2)
 ;;=^340570
 ;;^UTILITY(U,$J,358.3,16080,0)
 ;;=793.19^^92^932^2
 ;;^UTILITY(U,$J,358.3,16080,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16080,1,4,0)
 ;;=4^793.19
 ;;^UTILITY(U,$J,358.3,16080,1,5,0)
 ;;=5^Abn Chest Xray,Oth Finding, Lung
 ;;^UTILITY(U,$J,358.3,16080,2)
 ;;=^340571
 ;;^UTILITY(U,$J,358.3,16081,0)
 ;;=795.51^^92^932^32
 ;;^UTILITY(U,$J,358.3,16081,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16081,1,4,0)
 ;;=4^795.51
 ;;^UTILITY(U,$J,358.3,16081,1,5,0)
 ;;=5^Pos PPD w/o Active TB
 ;;^UTILITY(U,$J,358.3,16081,2)
 ;;=^340572
 ;;^UTILITY(U,$J,358.3,16082,0)
 ;;=795.52^^92^932^31
 ;;^UTILITY(U,$J,358.3,16082,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16082,1,4,0)
 ;;=4^795.52
 ;;^UTILITY(U,$J,358.3,16082,1,5,0)
 ;;=5^Pos GMA Interferon w/o Active TB
 ;;^UTILITY(U,$J,358.3,16082,2)
 ;;=^340573
 ;;^UTILITY(U,$J,358.3,16083,0)
 ;;=V15.82^^92^932^21
 ;;^UTILITY(U,$J,358.3,16083,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16083,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,16083,1,5,0)
 ;;=5^H/O Tobacco Abuse
 ;;^UTILITY(U,$J,358.3,16083,2)
 ;;=^303405
 ;;^UTILITY(U,$J,358.3,16084,0)
 ;;=511.89^^92^932^27
 ;;^UTILITY(U,$J,358.3,16084,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16084,1,4,0)
 ;;=4^511.89
 ;;^UTILITY(U,$J,358.3,16084,1,5,0)
 ;;=5^Pleural Effusion NEC
 ;;^UTILITY(U,$J,358.3,16084,2)
 ;;=^336604
 ;;^UTILITY(U,$J,358.3,16085,0)
 ;;=511.9^^92^932^28
 ;;^UTILITY(U,$J,358.3,16085,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16085,1,4,0)
 ;;=4^511.9
 ;;^UTILITY(U,$J,358.3,16085,1,5,0)
 ;;=5^Pleural Effusion NOS
 ;;^UTILITY(U,$J,358.3,16085,2)
 ;;=^123973
 ;;^UTILITY(U,$J,358.3,16086,0)
 ;;=376.01^^92^933^25
 ;;^UTILITY(U,$J,358.3,16086,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16086,1,4,0)
 ;;=4^376.01
 ;;^UTILITY(U,$J,358.3,16086,1,5,0)
 ;;=5^Orbital Cellulitis
 ;;^UTILITY(U,$J,358.3,16086,2)
 ;;=^259068
 ;;^UTILITY(U,$J,358.3,16087,0)
 ;;=388.70^^92^933^26
 ;;^UTILITY(U,$J,358.3,16087,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16087,1,4,0)
 ;;=4^388.70
 ;;^UTILITY(U,$J,358.3,16087,1,5,0)
 ;;=5^Otalgia, Unsp
 ;;^UTILITY(U,$J,358.3,16087,2)
 ;;=^37811
 ;;^UTILITY(U,$J,358.3,16088,0)
 ;;=380.10^^92^933^27
 ;;^UTILITY(U,$J,358.3,16088,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16088,1,4,0)
 ;;=4^380.10
 ;;^UTILITY(U,$J,358.3,16088,1,5,0)
 ;;=5^Otitis Externa,Infect
 ;;^UTILITY(U,$J,358.3,16088,2)
 ;;=^62807
 ;;^UTILITY(U,$J,358.3,16089,0)
 ;;=381.01^^92^933^31
 ;;^UTILITY(U,$J,358.3,16089,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16089,1,4,0)
 ;;=4^381.01
 ;;^UTILITY(U,$J,358.3,16089,1,5,0)
 ;;=5^Otitis Media, Serous Acute
 ;;^UTILITY(U,$J,358.3,16089,2)
 ;;=^269369
 ;;^UTILITY(U,$J,358.3,16090,0)
 ;;=382.9^^92^933^28
 ;;^UTILITY(U,$J,358.3,16090,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16090,1,4,0)
 ;;=4^382.9
 ;;^UTILITY(U,$J,358.3,16090,1,5,0)
 ;;=5^Otitis Med, Other Acute
 ;;^UTILITY(U,$J,358.3,16090,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,16091,0)
 ;;=382.01^^92^933^30
 ;;^UTILITY(U,$J,358.3,16091,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16091,1,4,0)
 ;;=4^382.01
 ;;^UTILITY(U,$J,358.3,16091,1,5,0)
 ;;=5^Otitis Media W/Tympanic Membrane Rupture
 ;;^UTILITY(U,$J,358.3,16091,2)
 ;;=^269396
 ;;^UTILITY(U,$J,358.3,16092,0)
 ;;=381.10^^92^933^29
 ;;^UTILITY(U,$J,358.3,16092,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16092,1,4,0)
 ;;=4^381.10
 ;;^UTILITY(U,$J,358.3,16092,1,5,0)
 ;;=5^Otitis Med, Serous Chronic
 ;;^UTILITY(U,$J,358.3,16092,2)
 ;;=Otitis Med,serous chroinic^269376
 ;;^UTILITY(U,$J,358.3,16093,0)
 ;;=379.91^^92^933^32
